GSK plans 60 job cuts at Quebec vaccine plant

GlaxoSmithKline ($GSK) plans to cut 9% of its Quebec City workforce, with most of the cuts coming at a vaccines plant that produces seasonal flu shots. About 60 jobs are expected to be affected by the move. Report

Suggested Articles

The FDA has granted Amarin's Vascepa a possible blockbuster label expansion for CV risk reduction in patients with or without CV disease.

In a high-stakes patent lawsuit between CAR-T companies Bristol-Myers Squibb and Gilead Sciences, BMS has come up with a victory. 

It’s been a year of ups and downs for Pfizer’s Xeljanz. But the company is hoping to close on a high note, with help from a new extended-release pill.